These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12401303)

  • 1. The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis.
    Banerjea MC; Speer CP
    Semin Neonatol; 2002 Aug; 7(4):335-49. PubMed ID: 12401303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of myeloid colony-stimulating factors in neonates with septicemia.
    Bernstein HM; Calhoun DA; Christensen RD
    Curr Opin Pediatr; 2002 Feb; 14(1):91-4. PubMed ID: 11880741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid hematopoietic growth factors and their role in prevention and/or treatment of neonatal sepsis.
    Parravicini E; van de Ven C; Anderson L; Cairo MS
    Transfus Med Rev; 2002 Jan; 16(1):11-24. PubMed ID: 11788926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid colony-stimulating factors: use in the newborn.
    Sreenan C; Osiovich H
    Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates.
    Bracho F; Goldman S; Cairo MS
    Curr Opin Hematol; 1998 May; 5(3):215-20. PubMed ID: 9664163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
    Ahmad A; Laborada G; Bussel J; Nesin M
    Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
    Lehrnbecher T
    Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation.
    Carr R; Modi N; Doré CJ; El-Rifai R; Lindo D
    Pediatrics; 1999 Apr; 103(4 Pt 1):796-802. PubMed ID: 10103305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
    Carr R; Brocklehurst P; Doré CJ; Modi N
    Lancet; 2009 Jan; 373(9659):226-33. PubMed ID: 19150703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and potential use of cytokines in the prevention and treatment of neonatal sepsis.
    Goldman S; Ellis R; Dhar V; Cairo MS
    Clin Perinatol; 1998 Sep; 25(3):699-710. PubMed ID: 9779342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in the prophylaxis and treatment of neonatal sepsis.
    Suri M; Harrison L; Van de Ven C; Cairo MS
    Curr Opin Pediatr; 2003 Apr; 15(2):155-60. PubMed ID: 12640271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
    Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
    Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis in babies: should we stimulate the phagocytes?
    Shann F
    Lancet; 2009 Jan; 373(9659):188-90. PubMed ID: 19150690
    [No Abstract]   [Full Text] [Related]  

  • 14. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia.
    Mohan P; Brocklehurst P
    Cochrane Database Syst Rev; 2003; (4):CD003956. PubMed ID: 14584000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation, part II: granulocyte colony-stimulating factors.
    Bell SG
    Neonatal Netw; 2006; 25(1):65-70. PubMed ID: 16514867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
    Castagnola E; Dufour C
    Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations on the use of colony-stimulating factors in children: conclusions of a European panel.
    Schaison G; Eden OB; Henze G; Kamps WA; Locatelli F; Ninane J; Ortega J; Riikonen P; Wagner HP
    Eur J Pediatr; 1998 Dec; 157(12):955-66. PubMed ID: 9877032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal neutropenia: what diagnostic evaluation is needed and when is treatment recommended?
    Del Vecchio A; Christensen RD
    Early Hum Dev; 2012 May; 88 Suppl 2():S19-24. PubMed ID: 22633505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the rationale for the use of granulocyte and granulocyte-macrophage colony-stimulating factors in the neonatal intensive care unit?
    La Gamma EF; De Castro MH
    Acta Paediatr Suppl; 2002; 91(438):109-16. PubMed ID: 12477273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of colony stimulating factors in cancer therapy.
    Morstyn G; Sheridan WP
    Cancer Chemother Biol Response Modif; 1991; 12():307-26. PubMed ID: 1718376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.